NCT07147348 2025-10-01A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid TumorsBioNTech SEPhase 1/2 Recruiting375 enrolled